Levetiracetam-associated high–anion gap metabolic acidosis and secondary ketogenesis: a case series
Clinical Kidney Journal · 01.05.2026 · 19 (5)
DOI: 10.1093/ckj/sfag109 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical Kidney Journal, online erschienen am 06.04.2026. Verfasst von Khaled Al-Baqain und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Marshall University Joan C. Edwards School of Medicine, Huntington, WV, USA. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Internal Medicine, Marshall University Joan C. Edwards School of Medicine, Huntington, WV, USA.
ORCID-Profile: Khaled Al-Baqain
Zitieren
APA
Al-Baqain, K., Sharawi, S., Khabbaz, O., Ghishan, S., Ash-Shawareb, Y., Kheetan, M., Shweihat, Y., & Khitan, Z. (2026). Levetiracetam-associated high–anion gap metabolic acidosis and secondary ketogenesis: a case series. Clinical Kidney Journal, 19(5). https://doi.org/10.1093/ckj/sfag109
Vancouver
Al-Baqain K, Sharawi S, Khabbaz O, Ghishan S, Ash-Shawareb Y, Kheetan M, et al. Levetiracetam-associated high–anion gap metabolic acidosis and secondary ketogenesis: a case series. Clinical Kidney Journal. 2026;19(5). doi:10.1093/ckj/sfag109
BibTeX
@article{AlBaqain2026,
author = {Al-Baqain, Khaled and Sharawi, Said and Khabbaz, Omar and Ghishan, Saif and Ash-Shawareb, Yanal and Kheetan, Murad and Shweihat, Yousef and Khitan, Zeid},
title = {Levetiracetam-associated high–anion gap metabolic acidosis and secondary ketogenesis: a case series},
journal = {Clinical Kidney Journal},
year = {2026},
volume = {19},
number = {5},
doi = {10.1093/ckj/sfag109}
}
EUVIMED